FdaApplication

NDA 209347

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEXELA PHARMA SCIENCES LLC
application_typeNDA
approval_date2017-02-17

Products (1)

ProductActive ingredientStrengthDosage form
GANZYK-RTUGANCICLOVIR500MG/250ML (2MG/ML)SOLUTION;INTRAVENOUS

1 product